- Home
- LUCY vs EVGN Comparison
LUCY vs EVGN Comparison
Compare LUCY & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- EVGN
- Stock Information
- Founded
- LUCY 2017
- EVGN 1999
- Country
- LUCY United States
- EVGN Israel
- Employees
- LUCY N/A
- EVGN N/A
- Industry
- LUCY Ophthalmic Goods
- EVGN Agricultural Chemicals
- Sector
- LUCY Health Care
- EVGN Industrials
- Exchange
- LUCY Nasdaq
- EVGN Nasdaq
- Market Cap
- LUCY 8.9M
- EVGN 9.7M
- IPO Year
- LUCY 2022
- EVGN N/A
- Fundamental
- Price
- LUCY $3.19
- EVGN $1.09
- Analyst Decision
- LUCY
- EVGN Strong Buy
- Analyst Count
- LUCY 0
- EVGN 1
- Target Price
- LUCY N/A
- EVGN $3.50
- AVG Volume (30 Days)
- LUCY 2.5M
- EVGN 47.1K
- Earning Date
- LUCY 05-13-2025
- EVGN 05-21-2025
- Dividend Yield
- LUCY N/A
- EVGN N/A
- EPS Growth
- LUCY N/A
- EVGN N/A
- EPS
- LUCY N/A
- EVGN N/A
- Revenue
- LUCY $1,707,470.00
- EVGN $6,765,000.00
- Revenue This Year
- LUCY $542.00
- EVGN $68.62
- Revenue Next Year
- LUCY $148.54
- EVGN $66.92
- P/E Ratio
- LUCY N/A
- EVGN N/A
- Revenue Growth
- LUCY 22.75
- EVGN N/A
- 52 Week Low
- LUCY $1.57
- EVGN $0.95
- 52 Week High
- LUCY $25.40
- EVGN $7.75
- Technical
- Relative Strength Index (RSI)
- LUCY 61.71
- EVGN 40.78
- Support Level
- LUCY $2.80
- EVGN $1.08
- Resistance Level
- LUCY $3.40
- EVGN $1.43
- Average True Range (ATR)
- LUCY 0.36
- EVGN 0.08
- MACD
- LUCY 0.11
- EVGN -0.01
- Stochastic Oscillator
- LUCY 79.98
- EVGN 8.11
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.